The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer (CRC): An analysis of 18,399 patients in the ARCAD database.
 
Anna Dorothea Wagner
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; EMD Serono; Lilly; Merck KGaA; MSD Oncology; Pfizer; Servier/Pfizer; Shire
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD Oncology; Sanofi
 
Manel Rakez
No Relationships to Disclose
 
Benoist Chibaudel
Consulting or Advisory Role - Bayer; Pfizer; Roche; Sanofi; Servier
Travel, Accommodations, Expenses - Amgen; Merck; MSD; Roche; Sanofi
 
Richard Adams
Honoraria - Amgen; Merck Serono; SERVIER
Consulting or Advisory Role - Amgen; Merck Serono; SERVIER
Speakers' Bureau - Merck Serono
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
John Raymond Zalcberg
Stock and Other Ownership Interests - Aimmune; Alnylam; Biomarin; Bluebird Bio; Cochlear; CSL Limited; Dova Pharmaceuticals; GW Pharmaceuticals; Juno Therapeutics; Kiadis Pharma; Kite, a Gilead company; Sage Therapeutics; TherapeuticsMD; Vertex
Honoraria - Gilead Sciences; Halozyme; Merck Serono; pfizer; Specialised Therapeutics; Targovax
Consulting or Advisory Role - Halozyme; Lipotek; Merck Serono; Merck Sharp & Dohme; Pfizer; Sirtex Medical; Targovax
Research Funding - AstraZeneca (Inst); Baxalta/Shire (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono (Inst); Pfizer (Inst); Roche (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Deciphera; Merck Serono; Merck Sharp & Dohme
 
Leonard B. Saltz
Research Funding - Taiho Pharmaceutical
 
Alan P. Venook
Consulting or Advisory Role - Bayer; Eisai; Halozyme; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bayer; Genentech; Halozyme; Roche
 
Hans-Joachim Schmoll
Honoraria - Amgen; Roche
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Roche
Research Funding - Amgen; Roche
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Jean-Yves Douillard
No Relationships to Disclose
 
Christophe Tournigand
Honoraria - Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
Consulting or Advisory Role - Bayer
Research Funding - Roche
Travel, Accommodations, Expenses - Bayer; MSD; Roche
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; MSD Oncology; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Servier (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical
 
Richard M. Goldberg
Honoraria - Amgen
Consulting or Advisory Role - Merck; Merck KGaA; Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Merck; Merck KGaA
 
J. Randolph Hecht
Honoraria - ARMO BioSciences; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Gritstone Bio; Halozyme; Ipsen; Merck; Roche
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); Forty Seven (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Advaxis; Lilly
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Roche
Speakers' Bureau - SERVIER
Research Funding - Merck
Travel, Accommodations, Expenses - Roche; SERVIER
 
Eduardo Diaz-Rubio
Research Funding - AMGEN (Inst); AstraZeneca (Inst); Merck Serono (Inst); ROCHE (Inst); Sysmex (Inst)
 
Axel Grothey
Honoraria - Aptitude Health; Elsevier; IMEDEX
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech/Roche; Lilly (Inst)
Research Funding - Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Qian Shi
Stock and Other Ownership Interests - Amgen; Johnson & Johnson
Consulting or Advisory Role - Yiviva
Research Funding - Celgene (Inst); Roche/Genentech (Inst)
 
Aimery De Gramont
No Relationships to Disclose